Owner Boehringer Ingelheim Vetmedica GmbH

Inventors Ziegler, Christina; Neubauer, Antonie

Agent Davies Collison Cave

Pub. Number AU-B-2003258517

PCT Number PCT/EP03/07730

PCT Pub. Number WO2004/009802

Priority 102 33 064.6 19.07.02 DE

Filing date 16 July 2003

Wipo publication date 9 February 2004

Acceptance publication date 7 May 2009

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/125 (2006.01) Medicinal preparations containing antigens or antibodies - Picornaviridae, e.g. calicivirus

A61K 39/245 (2006.01) Medicinal preparations containing antigens or antibodies - Herpetoviridae, e.g. herpes simplex virus

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/22 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/03 (2006.01) Peptides having more than 20 amino acids

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/34 (2006.01) Mutation or genetic engineering - Proteins from DNA viruses